Recognising the future leaders of oncology is fundamental to safeguarding tomorrow's driving force in innovation.
This collection will showcase the high-quality work of internationally recognized researchers in the early stages of their careers. We aim to highlight research by leading scientists of the future across the entire breadth of Molecular and Cellular Oncology, and present advances in theory, experiment, and methodology with applications to compelling problems.
Submissions to this Research Topic must fit an eligibility criteria. Please contact the Editorial Office at oncology@frontiersin.org with your CV and manuscript abstract.
While future innovations in Molecular and Cellular Oncology are yet to be discovered, this Research Topic will give us a hint at whom to follow.
Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in Frontiers in Oncology.
Recognising the future leaders of oncology is fundamental to safeguarding tomorrow's driving force in innovation.
This collection will showcase the high-quality work of internationally recognized researchers in the early stages of their careers. We aim to highlight research by leading scientists of the future across the entire breadth of Molecular and Cellular Oncology, and present advances in theory, experiment, and methodology with applications to compelling problems.
Submissions to this Research Topic must fit an eligibility criteria. Please contact the Editorial Office at oncology@frontiersin.org with your CV and manuscript abstract.
While future innovations in Molecular and Cellular Oncology are yet to be discovered, this Research Topic will give us a hint at whom to follow.
Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in Frontiers in Oncology.